Skip to content

clinical trial to evaluate the Effect of Durva Ghrita Aschyotana, Ksheerbala Tail 101 Pratimarsha Nasya and Triphaladi compound in the Management of Computer Vision Syndrome

The Effect of Durva Ghrita Aschyotana, Ksheerbala Tail 101 Pratimarsha Nasya and Triphaladi compound in the Management of Computer Vision Syndrome An Open Label Double Arm Randomized Controlled Clinical Trial - nil

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104688
Enrollment
102
Registered
2026-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H578- Other specified disorders of eye and adnexa

Interventions

None listed

Sponsors

DR RICHA MOHAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Willing to participate in the study Patients having the clinical features of CVS

Exclusion criteria

Exclusion criteria: a) The patients who are planning for ocular and/or lid surgeries within the study period b) Patients having uncontrolled systemic disease like diabetes, hypertension etc. c) Patients not willing to participate in the study. d) Severe cases of complications like corneal ulcer, Glaucoma Uveitis, etc. e) Allergic and inflammatory conditions of eye like Acute conjunctivitis, Vernal keratoconjunctivitis, giant papillary conjunctivitis etc. f) Patients on steroids, oral contraceptive pills, oestrogen replacement therapy or any other medication such as antispasmodic drugs like Atropine that may adversely affect the outcome of the study g) H/o hypersensitivity to the trial drug or any of its ingredients

Design outcomes

Primary

MeasureTime frame
Reduction in signs and symptoms of CVS Comparative efficacy of group A with Group B Timepoint: after trial

Secondary

MeasureTime frame
Change in ocular health in terms of visual acuity. Assessment of the trial drug for its pharmacognostical & phytochemical properties. Timepoint: after trial

Countries

India

Contacts

Public ContactDr Richa Mohan

Shri Krishna AYUSH University Kurukshetra,Haryana

drashukataria@gmail.com9416553131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026